Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor

Author(s): Koji Tomoo

Journal Name: Current Topics in Medicinal Chemistry

Volume 10 , Issue 7 , 2010

Become EABM
Become Reviewer


The cathepsins are a family of lysosomal cysteine proteases that are abundant in living cells and play important roles in intracellular proteolysis. Cathepsins are necessary for cell survival, and disruption of regulation of the activity of these enzymes causes serious diseases including allergy, atherosclerosis, muscular dystrophy, Alzheimers disease and cancer. Therefore, the design of inhibitors for cathepsins is important in development of therapeutic agents. This review will focus on the features of the tertiary structure and substrate-binding specificity of cathepsins B, L, S and K, based on X-ray crystal structures of their complexes with inhibitors. To illustrate an approach to drug design, an example of structure-based design of a cathepsin B-specific inhibitor is described.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [696 - 707]
Pages: 12
DOI: 10.2174/156802610791113441
Price: $65

Article Metrics

PDF: 19